跳至主要内容
临床试验/CTRI/2020/07/026271
CTRI/2020/07/026271招募中未知

To evaluate the efficacy of oral Coenzyme Q supplementation in children with migraine aged 6-18 years: A randomized double-blind, placebo-controlled trial.

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Children with age 6-18 years
  • 2.Newly diagnosed to have migraine with/without aura
  • 3.Not received any medication for migraine prophylaxis in the past three months
  • 4.Caregivers giving informed consent

排除标准

  • 1.Already on other prophylactic treatment for migraine
  • 2.Receiving any antioxidant/other herbal medication/nutraceuticals in the past three months
  • 3.Any major systemic illnessAny other associated neurological disorder
  • 4.Abnormality in neuroimaging (MRI brain/CT brain)

研究者

发起方
ICMR

相似试验

Role of oral Coenzyme Q supplementation in children... | 临床试验